JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | -60.5% | 12,811 | -48.8% | 0.00% | – |
Q2 2022 | $76,000 | -39.2% | 25,014 | +36.1% | 0.00% | – |
Q1 2022 | $125,000 | -46.1% | 18,373 | -34.0% | 0.00% | – |
Q4 2021 | $232,000 | -32.2% | 27,817 | -39.6% | 0.00% | – |
Q3 2021 | $342,000 | +5.2% | 46,020 | -3.6% | 0.00% | – |
Q2 2021 | $325,000 | -14.7% | 47,756 | +28.8% | 0.00% | – |
Q1 2021 | $381,000 | +58.8% | 37,067 | +8.2% | 0.00% | – |
Q4 2020 | $240,000 | -8.0% | 34,272 | +7.3% | 0.00% | – |
Q3 2020 | $261,000 | +125.0% | 31,935 | +90.0% | 0.00% | – |
Q2 2020 | $116,000 | – | 16,812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |